Jill Biden Reveals Former President Has Stage 4 Cancer

In early June 2026, former First Lady Jill Biden told NBC's Today show what many had suspected but few in the Biden inner circle had stated so plainly: "Joe will live with cancer till the rest of his life" [1]. The former president, now 83, was diagnosed in May 2025 with stage 4 prostate cancer that had metastasized to his bones — an aggressive form rated Gleason 9, the second-highest grade on the scale used to measure prostate cancer severity [2]. He has completed radiation therapy, remains on hormone treatment, and by most accounts continues to function — traveling by Amtrak, delivering speeches, working on a memoir — but has, in Jill Biden's words, "slowed down" [1].

The disclosure itself is not new. Biden's personal office announced the cancer diagnosis on May 18, 2025, two days after a routine physical uncovered a prostate nodule following increasing urinary symptoms [3]. What has changed is the candor. For the first time, Jill Biden has acknowledged that her husband would not have been fit to serve a second presidential term, a statement that raises difficult questions about what was known, when it was known, and who chose not to say it.

The Diagnosis: Gleason 9 and What It Means

Prostate cancer is the most commonly diagnosed cancer in American men, with roughly 3.7 million men living with the disease in the United States as of 2023 [4]. But not all prostate cancer is the same. The Gleason scoring system, which grades cancer cells on a scale from 6 to 10 based on how abnormal they appear under a microscope, is a primary indicator of aggressiveness. A Gleason score of 6 indicates a low-grade, slow-growing cancer. Biden's score of 9 — Grade Group 5 — indicates cells that bear little resemblance to normal prostate tissue and are highly likely to grow and spread rapidly [2].

The distinction between early and late-stage prostate cancer is stark. For men diagnosed with localized or regional prostate cancer, the five-year relative survival rate exceeds 99%. For those diagnosed with distant metastatic disease — cancer that has spread to the bones, lymph nodes, or other organs, as in Biden's case — that rate drops to approximately 37% [5].

Source: American Cancer Society / SEER

Data as of Jan 1, 2025CSV

Biden's cancer was described as "hormone-sensitive," which his office characterized as allowing for "effective management" [3]. Hormone-sensitive metastatic prostate cancer generally responds to androgen deprivation therapy, which blocks testosterone from fueling tumor growth. This is a meaningful distinction: hormone-sensitive cancers tend to respond better to initial treatment than castration-resistant forms, though most hormone-sensitive cancers eventually develop resistance over time [6].

Dr. Neha Vapiwala, the Eli J. Glatstein Endowed Professor of Radiation Oncology at the University of Pennsylvania, led the team that coordinated Biden's radiation treatments at Penn Medicine in Philadelphia [7]. Biden completed a course of radiation therapy in October 2025 after five weeks of treatment that required regular trips from Delaware to Philadelphia [7][1].

For a man of Biden's age, the five-year survival statistics carry an important caveat: a study in JAMA Network Open found that many deaths among elderly patients with metastatic prostate cancer are attributable to causes other than the cancer itself [8]. In other words, the cancer may not be what ultimately determines Biden's lifespan — but it will define how he lives.

The Timeline: What Was Known and When

The most contentious aspect of Biden's diagnosis is not the cancer itself but the timeline surrounding its discovery and the health assessments that preceded it.

On February 24, 2024, Biden's longtime personal physician, Dr. Kevin O'Connor, conducted the president's annual physical and declared him "fit for duty," adding that Biden "fully executes all of his responsibilities without any exemptions or accommodations" [9]. That assessment made no mention of prostate abnormalities. O'Connor had noted in 2019 that Biden was receiving treatment for an enlarged prostate — a benign condition common in older men — but no PSA (prostate-specific antigen) results or prostate-specific screening details appeared in the 2024 report [9].

Fourteen months later, Biden was diagnosed with an aggressive cancer that had already metastasized to his bones.

Standard medical guidelines from the U.S. Preventive Services Task Force generally recommend against routine PSA screening for men over 70, on the grounds that the risks of overdiagnosis and overtreatment outweigh the benefits for most older men [8]. But exceptions are made for patients with longer life expectancies, and Biden — who was receiving the most comprehensive medical care available to any individual on Earth as a sitting president — arguably fell into that category.

Jill Biden's own account complicates the timeline further. She told interviewers that while her husband was still president, she noticed him waking seven times a night for bathroom visits — a classic symptom of prostate trouble [1]. She said she assumed his doctors would follow up. It was only after leaving the White House in January 2025 that she insisted he see a urologist, leading to the discovery of the nodule [1].

The Physician Under Scrutiny

Dr. O'Connor has been Biden's physician since Biden's vice presidency. He is described as a close personal associate of the Biden family — a relationship that critics argue may have compromised the objectivity of his formal assessments [9]. O'Connor had served as Biden's primary physician throughout both the vice presidency and presidency, creating a continuity of care that proponents say ensured thorough familiarity with Biden's medical history, but that skeptics view as a potential conflict of interest.

Congressional Republicans have seized on the gap between O'Connor's "fit for duty" assessments and the subsequent cancer diagnosis. Senator John Cornyn wrote to Attorney General Pam Bondi urging a DOJ investigation, stating, "I fear the American people were deliberately misled about President Biden's health" [10]. Senator Ron Johnson launched a parallel investigation through the Senate Permanent Subcommittee on Investigations in May 2025 [10].

O'Connor declined to testify before the GOP-led Senate Judiciary Committee hearing on June 18, 2025, which examined who was "running the country" during Biden's alleged cognitive decline [11]. In June 2025, President Trump signed an executive order directing an investigation into whether Biden aides concealed his declining health and whether some administration actions were taken without the president's knowledge [10].

By March 2026, however, NBC News and The New York Times reported that the Justice Department had shelved its investigation into Biden's use of an autopen to sign documents [10]. The broader questions about health transparency remain unresolved.

How Many Americans Face the Same Diagnosis

Biden is far from alone. An estimated 156,812 Americans were living with metastatic prostate cancer as of January 2025, a figure that has risen steadily from approximately 92,000 in 2010 [4][12]. The increase reflects both improved survival due to better treatments and a rise in late-stage diagnoses.

Source: JNCI / PMC

Data as of Jan 1, 2025CSV

The financial burden of metastatic prostate cancer is substantial. Research published in the journal Cancer found that annual spending attributable to metastatic prostate cancer was approximately $55,949 per person-year for those with commercial insurance and $43,682 for those with employer-sponsored Medicare coverage [13]. Monthly costs increase by roughly $8,900 after initiation of FDA-approved agents for metastatic castration-resistant disease, driven largely by oral medications [13].

Biden's access to care stands in contrast to what a typical patient encounters. As a former president, Biden retains Secret Service protection and access to elite medical institutions. His treatment at Penn Medicine's radiation oncology program — one of the top cancer centers in the country — was coordinated by a leading specialist in the field [7]. A typical 83-year-old man on Medicare navigating a stage 4 diagnosis would face different constraints: longer wait times for specialist referrals, potential geographic barriers to reaching academic medical centers, and out-of-pocket costs that can reach tens of thousands of dollars annually [13].

No Law Requires Disclosure

There is no constitutional or statutory requirement for presidents — sitting or former — to disclose their health status to the public [14]. The Constitution sets only three qualifications for the presidency: natural-born citizenship, a minimum age of 35, and 14 years of U.S. residency. Medical fitness is not mentioned [14].

The 25th Amendment, ratified in 1967, addresses presidential incapacity but does not define a medical threshold or specify who should determine fitness for office [14]. Presidents are protected by HIPAA's medical privacy provisions like any other citizen, and the extent of public health disclosure has historically been left to each president's discretion [14].

The precedents are inconsistent. Franklin Roosevelt concealed the severity of his polio-related disability and cardiovascular disease throughout his presidency, dying in office in 1945 of a cerebral hemorrhage that his physicians had long seen coming [14]. Ronald Reagan's Alzheimer's disease was not publicly disclosed until 1994, five years after he left office, though questions about his cognitive state had circulated during his second term [14]. Woodrow Wilson suffered a debilitating stroke in 1919, and his wife Edith effectively managed presidential communications for months while his condition was hidden from Congress and the public.

Biden's case adds a new dimension: a cancer diagnosis that arrived months after leaving office but that raises retroactive questions about whether symptoms were present — and perhaps minimized — during his presidency.

Jill Biden's Evolving Statements

Jill Biden's public statements about her husband's health have shifted markedly over the past two years, and the evolution bears examination.

During the 2024 campaign, she was one of the most forceful defenders of the president's fitness. After the disastrous June 27, 2024 debate against Donald Trump — a performance that accelerated Biden's withdrawal from the race — Jill Biden publicly praised his effort. She later acknowledged that privately, the couple discussed how he had "messed up" and that she was "frightened out of my mind" during the debate, thinking he might be having a stroke [15].

In a June 2026 appearance on The View, she stated that "no one ever came to me and said, 'Jill, you know, Joe's aging or something's wrong'" [15]. Yet she simultaneously acknowledged noticing his frequent nighttime bathroom visits — a symptom that ultimately led to his cancer diagnosis [1].

When asked directly whether Biden could have served another four years, she responded: "Well, not from what I know now. I mean, my God, who knew? It was so shocking to get that cancer diagnosis" [15].

These statements raise an unavoidable question: if Jill Biden noticed urinary symptoms significant enough to prompt her to insist on a urologist visit after leaving the White House, were those symptoms not also present — and observable — while Biden was still president? And if they were, why did the White House medical team not act on them?

Defenders of the Bidens argue that the cancer may have developed rapidly, that urinary symptoms in an elderly man are extremely common and not necessarily indicative of cancer, and that hindsight makes every prior statement look worse than it was at the time. These are reasonable points. Prostate cancer can progress from undetectable to metastatic in a relatively short window, particularly with high-grade disease [8].

The Political Fallout

The cancer disclosure has landed in an already fraught political environment. The House Committee on Oversight and Government Reform released a staff report titled "The Biden Autopen Presidency: Decline, Delusion, and Deception in the White House," alleging that top advisors and Biden's personal physician concealed his mental and physical decline from the public [16].

For the Democratic Party, the implications extend well beyond Biden's personal health. The question of whether party leadership was complicit in minimizing Biden's decline during the 2024 campaign has become what The Week described as "the first real litmus test of the 2028" primary race [17]. Prospective 2028 candidates face a dilemma: criticize the handling of Biden's health and risk alienating his supporters, or avoid the subject and risk appearing complicit in the lack of transparency.

The broader debate about age in politics, already intensified by Biden's presidency, has gained new urgency. Biden was 81 when he left office; Trump is 80 as of 2026. The cancer diagnosis has renewed calls from both parties for more rigorous health standards for presidential candidates — though no specific legislation mandating health disclosures has advanced through Congress [17].

Democratic Party leadership has been, in one analyst's phrasing, "unwilling to reckon publicly" with its role in supporting Biden's campaign for as long as it did [17]. Whether the party implements stronger transparency standards going forward — or whether the issue fades as 2028 approaches — remains an open question.

What Comes Next

Biden's medical team has described his condition as "manageable," and aides say he remains engaged in public life [7]. He continues to travel, deliver speeches, and work on his memoir. But Jill Biden's acknowledgment that stage 4 cancer at 83, combined with the medications he takes, has "made life a little more difficult" is the most unvarnished assessment his family has offered [1].

The five-year survival rate of 37% for metastatic prostate cancer is a population-level statistic, not a personal prognosis [5]. Individual outcomes depend on treatment response, comorbidities, and the specific pattern of metastatic disease. Biden's access to world-class oncology care at Penn Medicine, his hormone-sensitive disease profile, and his completion of radiation therapy are all factors that work in his favor [7].

The questions that linger are not primarily medical. They are about institutional transparency, the limits of presidential privacy, the responsibilities of those closest to power, and whether the American political system can develop mechanisms to ensure that voters are not kept in the dark about the health of the people who govern them. Biden's cancer did not cause a constitutional crisis. But the circumstances surrounding its disclosure have exposed fault lines that the next health scare — and there will be one — will crack wide open.